Ceigall India IPO vs Emcure Pharma IPO

Comparision between Ceigall India IPO and Emcure Pharma IPO.

IPO Details

Ceigall India IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Ceigall India IPO	Emcure Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	ICICI Securities Limited Iifl Securities Ltd Jm Financial Limited	Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Ceigall India IPO is up to ₹1,252.66 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Ceigall India IPO is ₹401.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.

	Ceigall India IPO	Emcure Pharma IPO
Face Value	₹5 per share	₹10 per share
Issue Price (Lower)	₹380.00 per share	₹960.00 per share
Issue Price (Upper)	₹401.00 per share	₹1,008.00 per share
Issue Price (Final)	₹401.00 per share	₹1,008.00 per share
Discount (Retail)
Discount (Employee)	₹38.00 per share	₹90.00 per share
Market Lot Size	37 shares	14 shares
Fresh Issue Size	1,70,63,640 shares	79,36,507 shares
Fresh Issue Size (Amount)	up to ₹684.25 Cr	up to ₹800.00 Cr
OFS Issue Size	1,41,74,840 shares	1,14,28,839 shares
OFS Issue Size (Amount)	up to ₹568.41 Cr	up to ₹1,152.03 Cr
Issue Size Total	3,12,38,480 shares	1,93,65,346 shares
Issue Size Total (Amount)	up to ₹1,252.66 Cr	up to ₹1,952.03 Cr

IPO Timetable

Ceigall India IPO opens on Aug 01, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Ceigall India IPO and Emcure Pharma IPO is Aug 05, 2024, and Jul 05, 2024, respectively.

	Ceigall India IPO	Emcure Pharma IPO
Anchor Bid Date	Jul 31, 2024	Jul 02, 2024
Issue Open	Aug 01, 2024	Jul 03, 2024
Issue Close	Aug 05, 2024	Jul 05, 2024
Basis Of Allotment (Tentative)	Aug 06, 2024	Jul 08, 2024
Initiation of Refunds (Tentative)	Aug 07, 2024	Jul 09, 2024
Credit of Share (Tentative)	Aug 07, 2024	Jul 09, 2024
Listing date (Tentative)	Aug 08, 2024	Jul 10, 2024
Anchor Lockin End date 1	Sep 04, 2024	Aug 07, 2024
Anchor Lockin End date 2	Nov 03, 2024	Oct 06, 2024

Financials

Ceigall India IPO P/E ratio is 20.67, as compared to Emcure Pharma IPO P/E ratio of 34.55.

Ceigall India IPO

Emcure Pharma IPO

Financial

Ceigall India Limited Financial Information (Restated Consolidated)

Ceigall India Limited's revenue increased by 46.92% and profit after tax (PAT) rose by 81.81% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	2,592.19	1,827.82	959.14
Revenue	3,066.19	2,087.04	1,146.50
Profit After Tax	304.91	167.70	126.43
Net Worth	906.41	593.06	431.25
Total Borrowing	1,811.02	1,252.58	652.12
Amount in ₹ Crore

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,806.16	6,672.53	6,063.47
Revenue	6,715.24	6,031.72	5,918.86
Profit After Tax	527.58	561.85	702.56
Net Worth	2,952.28	2,501.13	1,987.55
Reserves and Surplus	2,722.40	2,293.77	1,791.03
Total Borrowing	2,091.94	2,202.42	2,102.19
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

99.99%

98.90%

Promoter Shareholding (Post-Issue)

82.06%

78.24%

P/E Ratio

20.67

34.55

Market Cap

₹6985.41 Cr.

₹19029.89 Cr.

ROE

33.57%%

16.90%%

ROCE

31.98%%

19.37%%

Debt/Equity

1.17

0.67

EPS

₹19.40

₹29.17

RoNW

33.57%%

16.87%%

Shares Offered

In the Ceigall India IPO retail investors (RII) are offered 1,09,16,012 shares while in Emcure Pharma IPO retail investors are offered 1,09,16,012 shares. Qualified institutional buyers (QIB) are offered 62,37,721 shares in Ceigall India IPO and 38,53,234 shares in Emcure Pharma IPO.

	Ceigall India IPO	Emcure Pharma IPO
Anchor Investor Reserveration	93,56,581 shares	57,79,850 shares
Market Maker Reserveration
QIB	62,37,721 shares	38,53,234 shares
NII	46,78,291 shares	28,89,926 shares
RII	1,09,16,012 shares	67,43,160 shares
Employee	55,096 shares	1,08,900 shares
Others
Total	2,18,87,120 shares	1,37,03,538 shares

Bids Received (Subscription)

Ceigall India IPO subscribed 14.01x in total, whereas Emcure Pharma IPO subscribed 67.87x.

	Ceigall India IPO	Emcure Pharma IPO
QIB (times)	31.26x	191.24x
NII (times)	14.83x	49.32x
Big NII (times)	16.28x	54.90x
Small NII (times)	11.92x	38.16x
RII (times)	3.82x	7.36x
Employee (times)	11.84x	8.81x
Other (times)
Total (times)	14.01x	67.87x

Compare with others

Ceigall India IPO	Emcure Pharma IPO
Premier Energies IPO	Brainbees Solutions (Firstcry) IPO
Interarch Building Products IPO	Ceigall India IPO
Orient Technologies IPO	Akums Drugs and Pharmaceuticals IPO
Unicommerce eSolutions IPO	Sanstar IPO
Brainbees Solutions (Firstcry) IPO	Bansal Wire IPO
Akums Drugs and Pharmaceuticals IPO	OLA Electric IPO
Sanstar IPO	Vraj Iron and Steel IPO
Bansal Wire IPO	Aasaan Loans IPO
Emcure Pharma IPO	Stanley Lifestyles IPO
OLA Electric IPO	DEE Piping Systems IPO

Comments

Add a public comment...